- AU$58.82m
- AU$64.29m
- AU$16.70m
Australia Stock Exchange release from CRYOSITE : Change of Director's Interest Notice
Brief: Cryosite Says HY Net Profit Attributable $1.2 Mln
Australia Stock Exchange release from CRYOSITE : Appendix 4d and Half Year accounts
Australia Stock Exchange release from CRYOSITE : PRE_NR Ends: 19:42:55
Brief: Cryosite Says Federal Court Approves In Principle Settlement Between Cryosite & ACCC
Brief: ACCC Says Federal Court Has Ordered Cryosite To Pay $1.05 Mln In Penalties
Brief: Cryosite Ltd Reaches In Principle Settlement With ACCC
Brief: Cryosite Ltd Says Co Expects To Report A Full Year Loss After Tax
Brief: Cryosite Says Notified By ACCC That It Has Filed Civil Proceedings Against Co
Brief: ACCC Says It Instituted Proceedings In Federal Court Against Cryosite Ltd
Brief: Cryosite Ltd Appoints Bryan Dulhunty As Non-Executive Chairman
Brief: Cryosite Appoints Mark Byrne As CEO
Brief: Cryosite says proposed transaction with Cell Care not able to be completed
Brief: Cryosite Says ACCC Informed Discontinuation of Review Of Deal with Cell Care Australia Pty
Brief: Cryosite expects to post first half FY 2018 net loss after tax
Brief: Cryosite says ACCC suspends timeline for review of Cellcare and Cryosite transaction
Brief: Cryosite says FY net profit for the period attributable $225,000
Brief: Cryosite says ACCC to review proposed license and sale of certain cord blood and tissue assets
Brief: Cryosite says Mark Byrne has been appointed interim CEO